thanks, Plasmid.
that's a mighty fine track record of their top 6 picks for each year.
I'll have a go at coming up with my own "top 6 picks" for 2017 and have a little competition with them!
I will definitely include FTT in my list. The only danger I see lurking from now on until just before results read-out is a slow recruitment.
It's annoying that the first patient took so long to happen, but the patient that really counts is the last patient in. Hopefully that patient happens sooner than expected rather than later!
- Forums
- ASX - By Stock
- DLM
- Ann: Phase II Clinical Trial - First Patient In
Ann: Phase II Clinical Trial - First Patient In, page-5
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online